|
US6025154A
(en)
|
1995-06-06 |
2000-02-15 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human G-protein chemokine receptor HDGNR10
|
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
SK40599A3
(en)
|
1996-09-26 |
2000-06-12 |
Chugai Pharmaceutical Co Ltd |
Antibody against human parathormone related peptides
|
|
US6733990B1
(en)
|
1999-08-03 |
2004-05-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like family
|
|
SE9801098D0
(sv)
*
|
1998-03-30 |
1998-03-30 |
Astra Pharma Prod |
Receptors
|
|
WO1999056532A1
(en)
*
|
1998-05-07 |
1999-11-11 |
William Douglas Mckee |
Valve assembly
|
|
US6171590B1
(en)
|
1998-09-30 |
2001-01-09 |
Corixa Corporation |
Chemokine receptor peptide for inducing an immune response
|
|
ES2275358T3
(es)
*
|
1998-11-06 |
2007-06-01 |
Bayer Healthcare Ag |
Receptores acoplados a proteina g, homologos al gpcr 2 (eb1-2) inducido por ebv. procedimientos para buscar ligandos de los mismos.
|
|
US6329159B1
(en)
*
|
1999-03-11 |
2001-12-11 |
Millennium Pharmaceuticals, Inc. |
Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
|
|
US6358697B2
(en)
|
1999-04-21 |
2002-03-19 |
Children's Hospital Medical Center |
Intracellular pharmaceutical targeting
|
|
WO2001038352A2
(en)
*
|
1999-11-24 |
2001-05-31 |
Schering Corporation |
Methods of inhibiting metastasis
|
|
US6949243B1
(en)
|
1999-11-24 |
2005-09-27 |
Schering Corporation |
Methods of inhibiting metastasis
|
|
WO2001072334A2
(en)
*
|
2000-03-27 |
2001-10-04 |
Corixa Corporation |
Methods for treating disease with antibodies to cxcr3
|
|
US8029793B2
(en)
|
2000-04-28 |
2011-10-04 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for inhibiting cell proliferation
|
|
US7052676B2
(en)
|
2000-09-26 |
2006-05-30 |
The Regents Of The University Of Michigan |
Methods for inhibition of HIV replication using a small molecule inhibitor
|
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
|
JP2005501036A
(ja)
*
|
2001-07-12 |
2005-01-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
二次的な組織変性のｃｘｃｌ１０処置
|
|
US7871619B2
(en)
|
2001-11-30 |
2011-01-18 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7413866B2
(en)
|
2001-11-30 |
2008-08-19 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7253007B2
(en)
|
2001-11-30 |
2007-08-07 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7442512B2
(en)
|
2001-11-30 |
2008-10-28 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7393934B2
(en)
|
2001-12-21 |
2008-07-01 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor (CCR5) HDGNR10
|
|
EP1491209A4
(en)
*
|
2002-02-28 |
2006-05-17 |
Kyowa Hakko Kogyo Kk |
MEANS FOR DIAGNOSIS AND TREATMENT OF INTERSTITIAL PNEUMONIA
|
|
JPWO2003082335A1
(ja)
*
|
2002-04-03 |
2005-07-28 |
住友製薬株式会社 |
新規血糖調節薬及びそのスクリーニング方法
|
|
EP2399903A1
(en)
|
2002-05-24 |
2011-12-28 |
Millennium Pharmaceuticals, Inc. |
Ccr9 inhibitors and methods of use thereof
|
|
US7227035B2
(en)
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
US6939885B2
(en)
|
2002-11-18 |
2005-09-06 |
Chemocentryx |
Aryl sulfonamides
|
|
US7741519B2
(en)
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
ATE427933T1
(de)
|
2002-12-20 |
2009-04-15 |
Chemocentryx Inc |
Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor
|
|
US7834155B2
(en)
|
2003-07-21 |
2010-11-16 |
Immunogen Inc. |
CA6 antigen-specific cytotoxic conjugate and methods of using the same
|
|
WO2005030793A2
(en)
*
|
2003-09-24 |
2005-04-07 |
Millennium Pharmaceuticals, Inc. |
Antibodies which bind human cxcr3
|
|
US20090208486A1
(en)
*
|
2004-03-09 |
2009-08-20 |
Makoto Taketo |
Pharmaceutical composition comprising cxcr3 inhibitor
|
|
WO2005105841A2
(en)
|
2004-03-12 |
2005-11-10 |
Human Genome Sciences, Inc. |
Human g-protein chemokine receptor (ccr5) hdgnr10
|
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
WO2006116319A2
(en)
|
2005-04-21 |
2006-11-02 |
Chemocentryx, Inc. |
Reagents that bind ccx-ckr2
|
|
CA2646931C
(en)
|
2006-03-16 |
2016-05-24 |
Protagonists Ltd. |
Combination of cytokine and cytokine receptor for altering immune system functioning
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
US8435522B2
(en)
*
|
2007-02-01 |
2013-05-07 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against CXCR3
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
PL2175859T3
(pl)
|
2007-07-12 |
2012-09-28 |
Chemocentryx Inc |
Skondensowane heteroarylopirydylo- i fenylo-benzenosulfonamidy jako modulatory CCR2 do leczenia zapalenia
|
|
SG10201700735PA
(en)
*
|
2012-01-20 |
2017-02-27 |
Genzyme Corp |
Anti-cxcr3 antibodies
|
|
HK1212628A1
(zh)
*
|
2012-06-27 |
2016-06-17 |
吉安特科技公司 |
用於抑制炎症的抗-cxcl9、抗-cxcl10、抗-cxcl11、抗-cxcl13、抗-cxcr3和抗-cxcr5试剂
|
|
US9681647B2
(en)
|
2012-07-05 |
2017-06-20 |
Cornell University |
Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using
|
|
WO2014186842A1
(en)
*
|
2013-05-22 |
2014-11-27 |
Monash University |
Antibodies and uses thereof
|
|
MX2021014356A
(es)
|
2016-11-23 |
2022-11-24 |
Chemocentryx Inc |
Metodo para tratar glomeruloesclerosis segmentaria focal.
|
|
US10610104B2
(en)
|
2016-12-07 |
2020-04-07 |
Progenity, Inc. |
Gastrointestinal tract detection methods, devices and systems
|
|
CA3045310A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
|
AU2018347361A1
(en)
|
2017-10-11 |
2020-04-30 |
Chemocentryx, Inc. |
Treatment of focal segmental glomerulosclerosis with CCR2 antagonists
|
|
US20220249814A1
(en)
|
2018-11-19 |
2022-08-11 |
Progenity, Inc. |
Methods and devices for treating a disease with biotherapeutics
|
|
CN121197633A
(zh)
|
2019-12-13 |
2025-12-26 |
比特比德科有限责任公司 |
用于将治疗剂递送至胃肠道的可摄取装置
|
|
WO2022152767A2
(en)
*
|
2021-01-12 |
2022-07-21 |
Charité - Universitätsmedizin Berlin |
A cxcr3+ cell or cell preparation for use in cancer treatment
|
|
WO2025185738A1
(zh)
*
|
2024-03-08 |
2025-09-12 |
演生潮(北京)生物科技有限公司 |
靶向cxcr3的抗原结合蛋白及其应用
|